Hendrik Wichmann is highly respected for his “excellent knowledge of the life sciences sector” as well as his “profound understanding of technical matters in patents covering pharmaceutical inventions”.
Dr Wichmann is a German and European patent attorney with more than 20 years of experience in intellectual property, advising and representing global clients operating in the biotech, chemistry and pharma industries as well as in the field of plant variety protection up to the Court of Justice of the EU (CJEU). He has extensive expertise in all aspects of patent practice, including drafting and prosecuting patent applications and large portfolios, and conducting numerous complex opposition and appeal proceedings before the EPO. Dr Wichmann has been actively involved in multinational patent litigation in food chemistry, and in the field of pharmaceutical antibodies. In the context of strategic consultations, his team conducts comprehensive complex freedom-to-operate analyses and portfolio assessments. He is listed on a regular basis in, for example, Intellectual Asset Management (IAM) magazine's “IAM Patent 1000” list and JUVE, and has repeatedly been selected by MIP as one of its IP Stars.
In addition, he has authored numerous publications, focusing particularly on European patent law, and serves as a speaker at several events, such as the BIO IPCC Conference. On a yearly basis, in collaboration with a legal member of the Boards of Appeal of the EPO, he conducts an established master class on EPO opposition and appeal proceedings.
Since 2012 he has served as the chairman of the committee for biotechnology of the chartered Institute of German Patent Attorneys, having been a vice chairman for several years.
He holds a doctorate from the Max-Planck-Institute for Biophysical Chemistry in Göttingen, Germany, after having studied biology with a focus on biochemistry at the Universities of Bonn and Cologne.